Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor effects of irofulven in advanced cancer

Dec. 3, 2003

Antitumor effects of TZT-1027 in advanced cancer patients

Dec. 2, 2003

Efficacy and tolerance of MS-275 in patients with refractory tumors

Dec. 2, 2003

Progression-free survival prolonged in Avastin study in colorectal cancer

Dec. 1, 2003

Enrollment completed in STELLAR 3 pivotal trial of Xyotax

Dec. 1, 2003

Antiangiogenic and antiproliferative effects described for AP-23573 in tumor cells

Dec. 1, 2003

Plenaxis receives FDA approval

Nov. 28, 2003

Introgen and SWOG to evaluate Advexin plus surgery in phase II trial

Nov. 28, 2003

Antisoma and EMD Lexigen create immunocytokine fusion protein

Nov. 28, 2003

Preliminary phase I results on EKB-569 for advanced colorectal cancer

Nov. 28, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...